Dyne Therapeutics (NASDAQ:DYN) Stock Price Down 6.4% After Analyst Downgrade
Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report)’s share price was down 6.4% during mid-day trading on Monday after Piper Sandler lowered their price target on the stock from $53.00 to $48.00. Piper Sandler currently has an overweight rating on the stock. Dyne Therapeutics traded as low as $12.81 and last traded at $12.74. Approximately […]
